Mirion Medical Announced Attaining CE Mark Per EU Medical Device Regulation For The SunSCAN 3D Cylindrical Water Scanning System
Portfolio Pulse from Benzinga Newsdesk
Sun Nuclear, a subsidiary of Mirion Medical (NYSE:MIR), has attained the CE mark per EU Medical Device Regulation for the SunSCAN 3D cylindrical water scanning system. The system, which supports linear accelerator commissioning, beam scanning, and annual Quality Assurance in Radiation Therapy, has seen widespread adoption since its release in May 2022.
September 28, 2023 | 9:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The CE mark for Sun Nuclear's SunSCAN 3D system could potentially boost Mirion Medical's market presence in the EU. This regulatory approval may lead to increased sales and revenue for the company.
The CE mark is a regulatory approval that allows a product to be sold in the European Economic Area. This approval for the SunSCAN 3D system could potentially open up a large market for Mirion Medical, leading to increased sales and revenue. The news is highly relevant as it directly involves Mirion Medical and its product. The importance is high as regulatory approvals can significantly impact a company's financial performance. The confidence in this analysis is high based on the information provided in the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100